Biosynthesis of the second and fourth components of complement: inhibition in vitro by chemical carcinogens.
D000588:Amines / Q000494:pharmacology; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D001391:Azo Compounds / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002273:Carcinogens / Q000494:pharmacology*; D003165:Complement System Proteins / Q000096:biosynthesis*; D004912:Erythrocytes / Q000276:immunology; D006168:Guinea Pigs; D007783:Lactones / Q000494:pharmacology; D008099:Liver / Q000276:immunology; D009602:Nitrosamines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000276:immunology
D000588:Amines; D000596:Amino Acids; D001391:Azo Compounds; D002250:Carbon Radioisotopes; D002273:Carcinogens; D007783:Lactones; D009602:Nitrosamines; D011804:Quinolines; D003165:Complement System Proteins